Our View: Troubling signs in SLO’s fight against COVID; A golden opportunity at Channel Islands Harbor
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Central Coast Health Watch: Ventura County masks up; Cottage honored; CenCal pays for senior meals
Ventura County’s public health officer, Dr. Robert Levin, issued an order requiring masks indoors in most public settings starting Aug. 23, joining a mask mandate already in effect in Santa Barbara County. San Luis Obispo County is not requiring masks, though it has the region’s highest rate of new COVID-19 cases and lowest vaccination rate. Read More →
Arcutis starts new Phase 3 trial
Arcutis Biotherapeutics announced Aug. 25 that it has enrolled the first patient in a Phase 3 clinical trial to evaluate ARQ-154, its topical foam, as a treatment for scalp and body psoriasis. The foam is a once-daily formulation of roflumilast, a phosphodiesterase type 4 inhibitor that the company is developing to treat two skin conditions: Read More →
Dignity, Anthem settle health coverage dispute
Dignity Health and Anthem Blue Cross have reached a new multi-year contract agreement that allows Anthem-insured customers to maintain in-network access to Dignity Health providers and facilities. On Aug. 16, the two organizations announced the agreement, which returns Dignity Health providers in the Tri-Counties to Anthem health plans, with no gap in coverage. The contract Read More →
Revenue and losses both growing at MannKind
MannKind saw a significant rise in revenue thanks to its product Afrezza, but its net loss in the second quarter of fiscal year 2021 also rose significantly as the company tried to pay down its debt. The Westlake Village biotech company released its earnings after the markets closed on Aug. 11. It opened the next Read More →
Santa Barbara County brings back mask rule, with region’s lowest rate of new COVID cases
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Atara losses grew in Q2
Atara Biotherapeutics swallowed more losses in the second quarter of 2021, as the early-stage company hopes for good news for its tab-cel therapy in early 2022. Atara, an immunotherapy biotech company based in South San Francisco with some of its major operations in Thousand Oaks, had a net loss of $83.7 million in the second Read More →
